Toxicology and Pharmacological Interactions of Classic Psychedelics.
Current Topics in Behavioral Neurosciences July 24, 2024 DOI: 10.1007/7854_2024_508 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Drug safety toxicology Adverse effects Drug–drug interactions Psychedelics hallucinogens Biotransformation Entheogens Medication interactions Metabolism pharmacokinetics Therapeutic use clinical |
| Citations | 3 |
| Key findings | The chapter summarizes the known toxicology and drug-drug interactions for several classic psychedelics. |
Abstract
As psychedelics are being investigated for more medical indications, it has become important to characterize the adverse effects and pharmacological interactions with these medications. This chapter will summarize what is known about the toxicology and drug-drug interactions for classic psychedelics, such as LSD, psilocybin, DMT, 5-MeO-DMT, mescaline, 2C-B, Bromo-DragonFLY, and 25X-NBOMe.